ORIC Pharmaceuticals, Inc. (ORIC) Tops Q1 EPS by 9c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q1 EPS of ($0.42), $0.09 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Coherent posts a blowout Q4 and aggressive guidance, yet shares take a 5% haircut
• Kimball Electronics (KE) Misses Q4 EPS by 42c; Offers Guidance
• BioStem Technologies, Inc. (BSEM) Misses Q3 EPS by 44c; offers guidance